Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

Published Date: 02 Oct 2025

Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell lung cancer were reported ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Unlocking the potential of targeted therapies for multiple myeloma

2.

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

3.

Early Results for Anorexia Nervosa with Psilocybin.

4.

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

5.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot